COMMUNIQUÉS West-GlobeNewswire

Opticore Eye Group Unveils New Contact Lens Program in Riverside, CA for 2026
17/04/2026
Announces new contact lens program. Riverside, California, United States, April 17, 2026 (GLOBE NEWSWIRE) -- Opticore Eye Group, a leader in comprehensive eye care, is thrilled to announce the launch of its innovative [...]
JellyLean Claims Evaluated: Discover the Untold Truth About Jelly Lean Gelatin Trick Gummies Recipe for Weight Loss
17/04/2026
A 2026 informational overview addresses growing consumer interest in JellyLean gummies, the gelatin trick weight loss recipe trend, ingredient research context, pricing, and what adults searching for jelly lean [...]
Yuhua Zhang, PhD, Named Chairholder of the Carolyn and Chuck Miller Endowed Chair for Vision Research
17/04/2026
PASADENA, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions for nearly 80 years, named Yuhua Zhang, PhD, chairholder of the Carolyn and Chuck [...]
Genmab A/S Share Capital Reduction
17/04/2026
Company Announcement COPENHAGEN, Denmark; April 17, 2026 – Genmab A/S (Nasdaq: GMAB) At Genmab A/S’ Annual General Meeting on March 19, 2026, it was decided to reduce the Company’s share capital with nominally DKK 1,900 [...]
Dogecoin Cash, Inc. (OTCQB: DOGP) Announces Development Initiative for “Dogecoin Gold” Digital Asset Framework
17/04/2026
MESQUITE, NV, April 17, 2026 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP) (“DOGP” or the “Company”) today announced it is advancing the development of “Dogecoin Gold,” a proposed blockchain-based digital asset [...]
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
17/04/2026
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “ [...]
Global Widget Celebrates 10 Years as a Leader in Premium Gummy Manufacturing
17/04/2026
Global Widget, LLC, a leading U.S.-based contract manufacturer specializing in gummy supplements, is celebrating its 10-year anniversary after a decade of rapid growth and operational expansion. Tampa, Florida, April 17 [...]
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study Finds
17/04/2026
In a 12‑week comparative study, Omada GLP‑1 Care Track members, on average, lost more weight and saw greater improvements in body composition than controls, pointing to increased value for employers and health plans. [...]
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
17/04/2026
SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary [...]
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
17/04/2026
KUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “ Company ” or “ Alps Group ”), the parent company of Alps Life Sciences Inc. (“ Alps Holdco ”), a biotechnology research and healthcare [...]
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
17/04/2026
INBS implements enhanced security architecture to protect test integrity and donor data, strengthening upcoming FDA 510(k) submission NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: [...]
SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson
17/04/2026
EMJ Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between SRx Health Solutions and EMJX NORTH PALM BEACH, Fla., April 17, 2026 (GLOBE [...]
First Steps Developmental Services Expands Services in Woburn
17/04/2026
New After-School and Hybrid Home ABA programs for children under 6 WOBURN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Families of young children with autism and Down syndrome in Massachusetts continue to face long [...]
Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting
17/04/2026
Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase 3 development in DPNP New data on spasticity further validates the broader [...]
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
17/04/2026
– Updated presentation on Cogent’s potent pan-KRAS(ON) inhibitor, CGT1263, showcasing its selectivity profile which could lead to reduction in skin toxicity associated with multi-RAS inhibitors – Updated presentation on [...]
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
17/04/2026
WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange [...]
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
17/04/2026
Targets rare, high-burden genetic condition with no approved therapies; advances non-surgical treatment strategy for recurrent basal cell carcinoma PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. ( [...]
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
17/04/2026
WALTHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its new Repligen [...]
Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
17/04/2026
MELBOURNE, Australia and SAN FRANCISCO, April 17, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]

Pages